BlackRock’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$431M Sell
10,896,937
-367,505
-3% -$14.5M 0.01% 1152
2025
Q1
$340M Sell
11,264,442
-401,106
-3% -$12.1M 0.01% 1258
2024
Q4
$408M Buy
11,665,548
+852,525
+8% +$29.8M 0.01% 1206
2024
Q3
$433M Buy
10,813,023
+491,993
+5% +$19.7M 0.01% 1175
2024
Q2
$492M Buy
10,321,030
+549,139
+6% +$26.2M 0.01% 1015
2024
Q1
$424M Buy
9,771,891
+714,361
+8% +$31M 0.01% 1146
2023
Q4
$458M Sell
9,057,530
-57,097
-0.6% -$2.89M 0.01% 1072
2023
Q3
$413M Sell
9,114,627
-21,547
-0.2% -$977K 0.01% 1031
2023
Q2
$375M Buy
9,136,174
+153,928
+2% +$6.32M 0.01% 1127
2023
Q1
$321M Sell
8,982,246
-97,311
-1% -$3.48M 0.01% 1211
2022
Q4
$343M Buy
9,079,557
+143,495
+2% +$5.42M 0.01% 1147
2022
Q3
$395M Buy
8,936,062
+104,672
+1% +$4.63M 0.01% 965
2022
Q2
$327M Buy
8,831,390
+387,547
+5% +$14.3M 0.01% 1153
2022
Q1
$313M Sell
8,443,843
-95,439
-1% -$3.54M 0.01% 1321
2021
Q4
$260M Buy
8,539,282
+419,429
+5% +$12.8M 0.01% 1535
2021
Q3
$272M Sell
8,119,853
-59,813
-0.7% -$2.01M 0.01% 1482
2021
Q2
$326M Sell
8,179,666
-1,628,896
-17% -$65M 0.01% 1402
2021
Q1
$441M Buy
9,808,562
+58,060
+0.6% +$2.61M 0.01% 1100
2020
Q4
$551M Buy
9,750,502
+1,285,095
+15% +$72.7M 0.02% 827
2020
Q3
$402M Sell
8,465,407
-185,321
-2% -$8.79M 0.01% 876
2020
Q2
$510M Buy
8,650,728
+482,788
+6% +$28.5M 0.02% 695
2020
Q1
$386M Sell
8,167,940
-234,449
-3% -$11.1M 0.02% 749
2019
Q4
$508M Buy
8,402,389
+51,590
+0.6% +$3.12M 0.02% 794
2019
Q3
$500M Sell
8,350,799
-451,777
-5% -$27.1M 0.02% 749
2019
Q2
$566M Buy
8,802,576
+1,181,004
+15% +$75.9M 0.02% 674
2019
Q1
$619M Sell
7,621,572
-54,685
-0.7% -$4.44M 0.03% 615
2018
Q4
$415M Buy
7,676,257
+213,000
+3% +$11.5M 0.02% 749
2018
Q3
$385M Buy
7,463,257
+408,678
+6% +$21.1M 0.02% 955
2018
Q2
$294M Buy
7,054,579
+124,233
+2% +$5.18M 0.01% 1124
2018
Q1
$305M Sell
6,930,346
-42,260
-0.6% -$1.86M 0.01% 1057
2017
Q4
$351M Sell
6,972,606
-30,885
-0.4% -$1.55M 0.02% 944
2017
Q3
$355M Buy
7,003,491
+179,504
+3% +$9.1M 0.02% 886
2017
Q2
$347M Buy
6,823,987
+264,179
+4% +$13.4M 0.02% 865
2017
Q1
$264M Buy
6,559,808
+6,542,394
+37,570% +$263M 0.01% 1062
2016
Q4
$833K Sell
17,414
-1,541
-8% -$73.7K ﹤0.01% 1523
2016
Q3
$695K Sell
18,955
-82,238
-81% -$3.02M ﹤0.01% 1594
2016
Q2
$2.36M Sell
101,193
-75,463
-43% -$1.76M ﹤0.01% 1079
2016
Q1
$7.16M Sell
176,656
-10,553
-6% -$427K 0.01% 752
2015
Q4
$11.6M Buy
187,209
+63,388
+51% +$3.93M 0.02% 639
2015
Q3
$5.01M Sell
123,821
-34,154
-22% -$1.38M 0.01% 773
2015
Q2
$9.09M Sell
157,975
-113,103
-42% -$6.51M 0.01% 677
2015
Q1
$17.3M Buy
271,078
+114,013
+73% +$7.26M 0.02% 550
2014
Q4
$9.7M Buy
157,065
+153,700
+4,568% +$9.49M 0.01% 677
2014
Q3
$130K Sell
3,365
-1,570
-32% -$60.7K ﹤0.01% 1598
2014
Q2
$170K Sell
4,935
-78,545
-94% -$2.71M ﹤0.01% 1536
2014
Q1
$3.61M Sell
83,480
-37,444
-31% -$1.62M 0.01% 907
2013
Q4
$4.82M Buy
120,924
+117,387
+3,319% +$4.68M 0.01% 834
2013
Q3
$133K Hold
3,537
﹤0.01% 1575
2013
Q2
$95K Buy
+3,537
New +$95K ﹤0.01% 1664